CIK: 0001493215 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: May 24, 2016
Total Value ($000): $307,386
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 573,361 | $53,976 | 17.6% | $99.43 | -6.8% | — | 02043Q107 |
| — | La Jolla Pharmaceutical Co | 1,084,416 | $29,279 | 9.5% | $25.34 | — | — | 503459604 |
| OMER | Omeros Corp | 1,819,341 | $28,618 | 9.3% | $14.29 | -3.3% | — | 682143102 |
| — | Kite Pharma Inc | 418,935 | $25,815 | 8.4% | $58.27 | — | — | 49803L109 |
| — | Dicerna Pharmaceuticals Inc | 2,012,662 | $23,890 | 7.8% | $13.12 | — | — | 253031108 |
| — | Achillion Pharmaceuticals Inc | 1,988,914 | $21,460 | 7.0% | $10.93 | — | — | 00448Q201 |
| BCRX | BioCryst Pharmaceuticals Inc | 2,010,501 | $20,748 | 6.7% | $11.05 | -10.0% | — | 09058V103 |
| — | Mirati Therapeutics Inc | 385,456 | $12,180 | 4.0% | $34.42 | — | — | 60468T105 |
| — | Atara Biotherapeutics Inc. | 433,923 | $11,460 | 3.7% | $26.41 | — | — | 046513107 |
| — | Five Prime Therapeutics Inc | 257,236 | $10,675 | 3.5% | $22.81 | — | — | 33830X104 |
| — | Agenus Inc | 2,214,453 | $10,054 | 3.3% | $8.33 | — | — | 00847G705 |
| — | Celldex Therapeutics Inc | 637,238 | $9,992 | 3.3% | $20.17 | — | — | 15117B103 |
| — | Symmetry Surgical Inc | 879,623 | $8,093 | 2.6% | $8.78 | — | — | 87159G100 |
| BMY | Bristol-Myers Squibb Co | 109,701 | $7,546 | 2.5% | $45.99 | +1.5% | — | 110122108 |
| — | Corium International Inc | 743,865 | $6,040 | 2.0% | $11.14 | — | — | 21887L107 |
| — | Global Blood Therapeutics Inc | 175,156 | $5,663 | 1.8% | $37.52 | — | — | 37890U108 |
| — | Dyax Corp | 115,795 | $4,356 | 1.4% | $14.06 | — | — | 26746E103 |
| RGNX | Regenxbio Inc | 221,326 | $3,674 | 1.2% | $25.09 | -20.9% | — | 75901B107 |
| — | Lipocine Inc | 220,515 | $2,851 | 0.9% | $5.63 | — | — | 53630X104 |
| — | Accelerate Diagnostics Inc | 107,467 | $2,309 | 0.8% | $21.49 | — | — | 00430H102 |
| — | Invuity Inc | 202,808 | $1,789 | 0.6% | $13.39 | — | — | 46187J205 |
| — | CytRx Corp | 470,576 | $1,247 | 0.4% | $2.73 | — | — | 232828509 |
| MASI | Masimo Corp | 25,900 | $1,075 | 0.3% | $40.86 | -0.0% | — | 574795100 |
| ANIK | Anika Therapeutics Inc | 27,500 | $1,049 | 0.3% | $38.25 | 0.0% | — | 035255108 |
| MDRX | Allscripts Healthcare Solutions Inc | 48,000 | $738 | 0.2% | $13.76 | +4.2% | — | 01988P108 |
| — | Biopharmx Corp | 370,636 | $563 | 0.2% | $2.56 | — | — | 09072X101 |
| — | Genomic Health Inc | 15,000 | $528 | 0.2% | $21.13 | — | — | 37244C101 |
| NTRA | Natera Inc | 31,693 | $342 | 0.1% | $16.90 | -43.7% | — | 632307104 |
| — | bluebird bio Inc | 5,300 | $340 | 0.1% | $111.52 | — | — | 09609G100 |
| — | Nivalis Therapeutics Inc | 30,000 | $232 | 0.1% | $15.17 | — | — | 65481J109 |
| — | T2 Biosystems Inc. Cmn | 20,900 | $229 | 0.1% | $10.96 | — | — | 89853L104 |
| VCYT | Veracyte Inc | 25,000 | $180 | 0.1% | $9.52 | -29.3% | — | 92337F107 |
| — | Endologix Inc | 15,000 | $149 | 0.0% | $12.27 | — | — | 29266S106 |
| — | VIVO 01/15/2016 CALL 20 | 1,252 | $110 | 0.0% | — | — | CALL | 589584101 |
| ADAPY | Adaptimmune Therapeutics-adr | 7,055 | $85 | 0.0% | $18.35 | — | — | 00653A107 |
| — | NVRO 05/20/2016 PUT 50 | 142 | $37 | 0.0% | — | — | PUT | 64157F103 |
| BRK/B | Berkshire Hathaway Inc | 50 | $7 | 0.0% | $134.20 | 0.0% | — | 084670702 |
| — | USO 01/15/2016 CALL 25 | 13,850 | $7 | 0.0% | — | — | CALL | 91232N108 |